Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Computational and Structural Biotechnology Journal|November 7, 2024
HerpDock: A GUI-based gateway to HSV-1 molecular docking insightsSudhanshu Kumar Singh, Divya Kapoor, Deepak Shukla
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 5, 2023
Tolerability, pharmacokinetics, and anti-herpetic activity of orally administered BX795Tejabhiram Yadavalli, Sudhanshu Kumar Singh, Abhijit A Date, et al.
Mbio|January 23, 2026
A CDK-4EBP1 signaling axis drives HSV-1 replication and underscores a druggable pathway for potent antiviral interventionKrishnaraju Madavaraju, Tejabhiram Yadavalli, Sudhanshu Kumar Singh, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 4, 2026
Host-directed novel mechanistic insights of doxorubicin reveal its efficacy against drug-resistant HSV-1 underscoring risks with oncolytic virotherapyPankaj Sharma, Divya Kapoor, Sudhanshu Kumar Singh, et al.
Pathogens (Basel, Switzerland)|July 2, 2021
Heparan Sulfate Binding Cationic Peptides Restrict SARS-CoV-2 EntryRahul K Suryawanshi, Chandrashekhar D Patil, Raghuram Koganti, et al.
ACS Infectious Diseases|October 9, 2023
Oral Self-Nanoemulsifying System Containing Ionic Liquid of BX795 Is Effective against Genital HSV-2 Infection in MiceYogesh Sutar, Sudhanshu Kumar Singh, Sagar Dhoble, et al.
Antiviral Research|November 5, 2022
Putative targeting by BX795 causes decrease in protein kinase C protein levels and inhibition of HSV1 infectionRahul K Suryawanshi, Chandrashekhar D Patil, David Wu, et al.
International Journal of Pharmaceutics|February 22, 2026
Topical administration of in situ gelling formulation containing myricetin-polycarboxylate nanoparticles inhibits murine genital herpes infectionSudipta Mallick, Pankaj Sharma, Tejabhiram Yadavalli, et al.
Pageof 1